ImmunoShield Therapeutics
PrivateLast Round
Grant
Jun 9, 2025
Total Funding Raised
$298,364
Company Overview
ImmunoShield Therapeutics is a biotechnology company that develops cell encapsulation and immune tolerance technologies designed to reduce rejection and expand patient access to allogeneic cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmunoShield Therapeutics Comparables
Compare ImmunoShield Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Procyon Technologies LLC | 91% | |
| Encellin | 83% | |
| ALTuCELL | 81% | |
ImmunoShield Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 9, 2025 | ||||
| Grant | May 30, 2023 |
ImmunoShield Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2025
Received $1.88M from the National Institute of Diabetes and Digestive and Kidney Diseases.
- May 30, 2023
Received funding from the Flinn Foundation.
ImmunoShield Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmunoShield Therapeutics's valuation, stock price, and market status.